sotalol has been researched along with Short Bowel Syndrome in 1 studies
Sotalol: An adrenergic beta-antagonist that is used in the treatment of life-threatening arrhythmias.
sotalol : A sulfonamide that is N-phenylmethanesulfonamide in which the phenyl group is substituted at position 4 by a 1-hydroxy-2-(isopropylamino)ethyl group. It has both beta-adrenoreceptor blocking (Vaughan Williams Class II) and cardiac action potential duration prolongation (Vaughan Williams Class III) antiarrhythmic properties. It is used (usually as the hydrochloride salt) for the management of ventricular and supraventricular arrhythmias.
Short Bowel Syndrome: A malabsorption syndrome resulting from extensive operative resection of the SMALL INTESTINE, the absorptive region of the GASTROINTESTINAL TRACT.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The individual bioavailability of enterally administered drugs is usually uncertain in case of reduced bowel length." | 5.30 | [Bioavailability of sotalol in short bowel syndrome]. ( Bach, F; Claus, T; Juckenhöfel, S; Molter, G; Silomon, M, 1999) |
| "The individual bioavailability of enterally administered drugs is usually uncertain in case of reduced bowel length." | 1.30 | [Bioavailability of sotalol in short bowel syndrome]. ( Bach, F; Claus, T; Juckenhöfel, S; Molter, G; Silomon, M, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Silomon, M | 1 |
| Bach, F | 1 |
| Juckenhöfel, S | 1 |
| Claus, T | 1 |
| Molter, G | 1 |
1 other study available for sotalol and Short Bowel Syndrome
| Article | Year |
|---|---|
[Bioavailability of sotalol in short bowel syndrome].
Topics: Aged; Anti-Arrhythmia Agents; Biological Availability; Dose-Response Relationship, Drug; Female; Hum | 1999 |